Alabama Administrative Code Chapter 420-7-2 — Controlled Substances

420 Alabama Department of Public Health

Ala. Admin. Code r. 420-7-2-.01 Authority

(1) The Alabama Controlled Substances List, shown as Appendix to this Chapter, comprises a complete listing of said substances, pursuant to Code of Ala. 1975, Sections 20-2-1, et seq.

(2) The Controlled Substances List shall be published annually, reflecting the date of adoption and the effective date.

(3) As substances are designated, rescheduled or deleted as controlled substances, the appendix and other publications shall be amended accordingly by adding to said listing a slip-sheet of the action taken and the effective date. Each annual publication, as provided in (2) above, will contain any amendment occurring during that year.

History

• Author: Alabama Department of Public Health
• Authority: Code of Ala. 1975, §§20-2-1, et seq.
• Filed September 1, 1982.

Ala. Admin. Code r. 420-7-2-.02 Definitions

(1) Controlled Substance. A drug, substance or immediate precursor in Schedules I through V of Rule 420-7-2-.03 of this Chapter.

(2) Drug.

(a) Substances recognized as drugs in the official United States pharmacopoeia, official homeopathic pharmacopoeia of the United States or official national formulary or any supplement to any of them;

(b) Substances intended for use in the diagnosis, cure, mitigation, treatment or prevention of disease in man or animals;

(c) Substances (other than food) intended to affect the structure or any function of the body of man or animals; and

(d) Substances intended for use as a component of any article specified in paragraphs (a), (b) or (c) of this subdivision. Such term does not include devices or their components, parts or accessories.

(3) Immediate Precursor. A substance which the State Board of Pharmacy has found to be and by rule designates as being the principal compound commonly used or produced primarily for use and which is an immediate chemical intermediary used or likely to be used in the manufacture of a controlled substance, the control of which is necessary to prevent, curtail or limit manufacture.

(4) Marihuana. All parts of the plant Cannabis sativa L., whether growing or not, the seeds thereof, the resin extracted from any part of the plant and every compound, manufacture, salt, derivative, mixture or preparation of the plant, its seeds or resin. Such term does not include the mature stalks of the plant, fiber produced from the stalks, oil or cake made from the seeds of the plant, any other compound, manufacture, salt, derivative, mixture or preparation of the mature stalks (except the resin extracted therefrom), fiber, oil or cake or the sterilized seed of the plant which is incapable of germination.

(5) Narcotic Drug. Any of the following, whether produced directly or indirectly by extraction from substances of vegetable origin or independently by means of chemical synthesis or by a combination of extraction and chemical synthesis:

(a) Opium and opiate and any salt, compound, derivative or preparation of opium or opiate.

(b) Any salt, compound, isomer, derivative or preparation thereof which is chemically equivalent or identical with any of the substances referred to in paragraph (a), but not including the isoquinoline alkaloids of opium.

(c) Opium poppy and poppy straw.

(d) Coca leaves and any salt, compound, derivative or preparation of coca leaves and any salt, compound, isomer, derivative or preparation thereof which is chemically equivalent or identical with any of these substances, but not including decocainized coca leaves or extractions of coca leaves which do not contain cocaine or ecgonine.

(6) Opiate. Any substance having an addiction-forming or addiction-sustaining liability similar to morphine or being capable of conversion into a drug having addiction-forming or addiction sustaining liability. Such term does not include, unless specifically designated as controlled under this section, the dextrorotatory isomer of 3-methoxy-n-methylmorphinan and its salts (dextromethorphan). Such term does include its racemic and levorotatory forms.

(7) Opium Poppy. The plant of the species Papaver somniferum L., except its seeds.

(8) Poppy Straw. All parts, except the seeds, of the opium poppy, after mowing.

History

• Author: Alabama Department of Public Health
• Authority: Code of Ala. 1975, §§20-2-1, et seq.
• Filed September 1, 1982.

Ala. Admin. Code r. 420-7-2-.11 Prescription Drug Monitoring Program - Collection Of Fees To Support The Database

(1) Act No. 2004-443 requires that the following licensing boards shall assess a surcharge in the amount of $10.00 per year on the controlled substance registration certificate issued or renewed each year to a licensee of the respective boards in the State of Alabama. This requirement is to be implemented effective October 12, 2004. A list of the affected licensing boards follows:

(a) Alabama State Board of Medical Examiners

(b) Alabama Board of Optometry

(c) Alabama Board of Dental Examiners

(d) Alabama State Board of Veterinary Medical Examiners

(e) Alabama State Board of Podiatry

(2) By the 10th of each quarter, each affected licensing board shall remit payment of $10.00 for each controlled substance registration certificate issued or renewed. The remittance shall be made payable to the Alabama Department of Public Health, Office of Professional and Support Services.

(3) By October 30 of succeeding years, each affected licensing board shall certify the number of controlled substance registration certificates issued or renewed during the prior fiscal year. The certification shall be made to the Alabama Department of Public Health, Office of Professional and Support Services.

(4) Funds remitted to the Alabama Department of Public Health pursuant to this section shall be deposited into the Alabama State Controlled Substance Database Trust Fund. The funds shall be used exclusively for the development, implementation, operation, and maintenance of the controlled substances prescription database.

History

• Author: Charles C. Thomas, R.Ph., State Pharmacy Director
• Authority: Code of Ala. 1975, §§22-21-20, et. seq.
• New Rule: Filed February 18, 2005; effective March 25, 2005.

Ala. Admin. Code r. 420-7-2-.12 Prescription Drug Monitoring Program Reporting To Database By Dispensers

(1) Entities and practitioners that dispense controlled substances, Class II-V, shall report controlled substances prescription information to the Prescription Drug Monitoring Program database. These entities and practitioners include but are not limited to:

(a) Licensed pharmacies;

(b) Mail order pharmacies or pharmacy benefit programs filling prescriptions for or dispensing controlled substances to residents of Alabama; and

(c) Licensed physicians, dentists, podiatrists, and optometrists who dispense controlled substances.

(2) The reporting requirement in this rule does not apply to a controlled substance dispensed:

(a) By a pharmacy of a hospital, nursing home, or other inpatient health care facility if administered and used by a patient on the facility’s premises;

(b) By a practitioner if administered during the course of a patient’s treatment by injection, topical application, suppository administration, or oral administration; or

(c) By a practitioner as an appropriately labeled sample medication.

(3) Entities and practitioners shall submit reports as follows:

(a) Entities shall submit reports at least once daily by 11:59 p.m.

1. If an entity or practitioner does not dispense a controlled substance on a specific day, the entity or practitioner shall report that zero controlled substances were dispensed.

2. The daily reporting requirement does not apply on days that the entity or practitioner’s business is closed and no controlled substances are dispensed.

(b) Reports must be in electronic format according to American Society for Automation in Pharmacy Standards using the U.S. Postal Service’s Postal Addressing Standards.

1. If electronic transmission is not feasible, an entity or practitioner may request a waiver.

2. An entity or practitioner who receives a waiver may submit prescription information in an alternate format approved by the Prescription Drug Monitoring Program.

3. Entities and practitioners shall submit waiver requests and reports formatted pursuant to a valid waiver to:

Alabama Department of Public Health Prescription Drug Monitoring Program The RSA Tower, Suite 1010 P.O. Box 303017 Montgomery, AL 36130-3017 Fax: (334) 206-5663

4. Penalties for noncompliance/non-reporting:

(a) On a monthly basis or as designated by the Prescription Drug Monitoring Program, licensing boards shall supply an electronic listing to the Prescription Drug Monitoring Program of entities and practitioners required to report controlled substances.

(b) The Prescription Drug Monitoring Program will monitor the list of entities and practitioners provided by the licensing boards for compliance in reporting to the database.

(c) The Department will notify the appropriate licensing board of an entity or practitioner’s failure to report. Upon notification of a non-reporting entity or practitioner, the relevant licensing board shall investigate and report to the Department the outcome.

History

• Author: Nancy Bishop, R. Ph., State Pharmacy Director
• Authority: Code of Ala. 1975, §22-21-20, et. seq.
• New Rule: Filed October 20, 2005; effective November 24, 2005. Amended: Filed February 17, 2006; effective March 24, 2006. Amended: Filed October 20, 2014; effective November 24, 2014. Amended: Filed August 19, 2016; effective October 3, 2016.

Ala. Admin. Code r. 420-7-2-.13 Access To Database

(1) Subject to the limitations provided in Section 20-2-214 of the Code of Ala. 1975, the following persons and entities may access the Prescription Drug Monitoring Program database:

(a) Authorized representatives of the certifying boards;

(b) Licensed practitioners who have the authority to prescribe, dispense, or administer controlled substances;

(c) Designated employees of a licensed physician if the physician has the authority to prescribe, dispense, or administer controlled substances;

(d) Licensed certified registered nurse practitioners, licensed certified nurse midwives, and licensed assistants to physicians who are authorized to prescribe, dispense, or administer controlled substances pursuant to a Qualified Alabama Controlled Substance Registration Certificate;

(e) Licensed pharmacists;

(f) Federal and Alabama law enforcement authorities;

(g) Authorized representatives of the Alabama Medicaid Agency; and

(h) Other persons listed in Section 20-2-214 of the Code of Ala. 1975.

(2) Law enforcement authorities shall pre-register with the Prescription Drug Monitoring Program to receive an ID and password to access a request form. To request a report from the Prescription Drug Monitoring Program, law enforcement authorities shall:

(a) Identify the specific individual or health care licensee that is the subject of the request;

(b) Certify that the request is pursuant to an active investigation; and

(c) Declare that probable cause exists for the use of the requested information.

History

• Author: Charles C. Thomas, R. Ph., State Pharmacy Director §
• Authority: Code of Ala. 1975, 22-21-20, et. seq.
• New Rule: Filed October 20, 2005; effective November 24, 2005. Amended: Filed July 19, 2007; effective August 23, 2007. Amended: Filed November 13, 2007; effective December 18, 2007. Amended: Filed October 20, 2014; effective November 24, 2014.

Ala. Admin. Code r. 420-7-2-A Appendix Controlled Substances List

ALABAMA STATE BOARD OF HEALTH

ALABAMA DEPARTMENT OF PUBLIC HEALTH

ADMINISTRATIVE CODE

APPENDIX

CONTROLLED SUBSTANCES LIST

Controlled Substances List

(Adopted by Alabama State Board of Health

on January 16, 2025, effective January 16, 2025)

Schedule I

(a) Schedule I shall consist of the drugs and other substances, by whatever official name, common or usual name, or brand name designated, listed in this section. Each drug or substance has been assigned the DEA Controlled Substances Code Number set forth opposite it.

(b) Opiates. Unless specifically excepted or unless listed in another schedule, any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters and ethers, whenever the existence of such isomers, esters, ethers and salts is possible within the specific chemical designation (for purposes of 3-methylthiofentanyl only, the term isomer includes the optical and geometric isomers):

(c) Opium derivatives. Unless specifically excepted or unless listed in another schedule, any of the following opium derivatives, its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:

(d) Hallucinogenic substances. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, preparation, which contains any quantity of the following hallucinogenic substances, or which contains any of its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation (for purposes of this paragraph only, the term "isomer" includes the optical, position, and geometric isomers):

(e) A synthetic controlled substance that is any material, mixture, or preparation that contains any quantity of the following chemical compounds, their salts, isomers and salts of isomers, unless specifically excepted, whenever the existence of these salts, isomers and salts of isomers is possible within the specific chemical designation or compound:

(f) In addition to any material, mixture, or preparation that contains any quantity of the chemical compounds listed in paragraph (e), a synthetic controlled substance also includes the following chemical compounds, their salts, isomers, and salts of isomers, unless specifically excepted, whenever the existence of these salts, isomers, and salts of isomers is possible within the specific chemical designation or compound:

(g) A synthetic controlled substance analogue, being a material, mixture, or preparation that contains any chemical structure of which is chemically similar to the chemical structure of any other controlled substance in Schedule I or Schedule II or that satisfies any one of the following:

(h) A synthetic controlled substance or analogue in subdivision (g) or this subdivision does not include any of the following:

(i) A controlled substance analogue is treated as a controlled substance in Schedule I.

(j) After the Alabama Department of Forensic Sciences has determined a substance to be a synthetic controlled substance analogue under this section, the department shall notify the Alabama Department of Public Health with information relevant to scheduling as provided by Section 20-2-20.

(k) Depressants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:

(l) Stimulants. Unless specifically accepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers, and salts of isomers.

(m) Cannabimimetic agents. Unless specifically exempted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of cannabimimetic agents, or which contains their salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:

(n) Temporary listing of substances subject to emergency scheduling. Any material, compound, mixture, or preparation which contains any quantity of the following substances:

Schedule II

(a) Schedule II shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this section. Each drug or substance has been assigned the Controlled Substances Code Number set forth opposite it.

(b) Substances, vegetable origin or chemical synthesis. Unless specifically excepted or unless listed in another schedule, any of the following substances whether produced directly or indirectly by extraction from substances of vegetable origin, or independently by means of chemical synthesis, or by a combination of extraction and chemical synthesis.

1. Opium and opiate, and any salt, compound, derivative, or preparation of opium or opiate excluding apomorphine, thebaine-derived butorphanol, dextrorphan, nalbuphine, naldemedine, nalmefene, naloxegol, naloxone, 6β - naltrexol, naltrexone, and samidorphan, and their respective salts, but including the following:

2. Any salt, compound, derivative, or preparation thereof which is chemically equivalent or identical with any of the substances referred to in paragraph (b)(1) of this section except that these substances shall not include the isoquinoline alkaloids of opium.

3. Opium poppy and poppy straw.

4. Coca leaves (9040) and any salt, compound, derivative, or preparation of coca leaves (including cocaine (9041) and ecgonine (9180) and their salts, isomers, derivatives and salts of isomers, and derivatives), and any salt, compound, derivative, or preparation thereof which is chemically equivalent or identical with any of these substances, except that the substitutes shall not include:

5. Concentrate of poppy straw (the crude extract of Poppy straw in either liquid, solid or powder form which contains the phenanthrine alkaloids of the opium poppy)--- 9670

(c) Opiates. Unless specifically excepted or unless in another schedule any of the following opiates, including its isomers, esters, ethers, salts and salts of isomers, esters and ethers whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation, dextrorphan excepted:

(d) Stimulants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system:

(e) Depressants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:

(f) Hallucinogenic substances.

(g) Immediate precursors. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances:

(h) Any drug product exempted from control by the Federal Drug Enforcement Administration will also be exempted from the Alabama Controlled Substances List unless the State Committee of Public Health takes additional action.

Schedule III

(a) Schedule III shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this section. Each drug or substance has been assigned the DEA Controlled Substances Code Number set forth opposite it.

(b) Stimulants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers (whether optical, position, or geometric), and salts of such isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:

(c) Depressants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system:

(d) Nalorphine 9400

(e) Narcotic drugs. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation containing any of the following narcotic drugs, or their salts calculated as the free anhydrous base or alkaloid, in limited quantities as set forth below:

1. Any material, compound, mixture, or preparation containing any of the following narcotic drugs, or their salts calculated as the free anhydrous base or alkaloid, in limited quantities as set forth below:

2. Any material, compound, mixture, or preparation containing any of the following narcotic drugs or their salts, as set forth below:

(f) Anabolic steroids. Unless specifically excepted or unless listed in another schedule, any substance meeting the definition of anabolic steroid as set forth in § 1300.01 of this chapter, including any material, compound, mixture, or preparation containing any quantity of the following substances, including its salts, esters, and ethers (4000):

(g) Hallucinogenic substances.

(h) Any drug product exempted from control by the Federal Drug Enforcement Administration will also be exempted from the Alabama Controlled Substances List unless the State Committee of Public Health takes additional action.

Schedule IV

(a) Schedule IV shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this section. Each drug or substance has been assigned the DEA Controlled Substances Code Number set forth opposite it.

(b) Narcotic drugs. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation containing any of the following narcotic drugs, or their salts calculated as the free anhydrous base or alkaloid, in limited quantities as set forth below:

(c) Depressants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation which contains any quantity of the following substances, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:

(d) [Reserved]

(e) Lorcaserin. Any material, compound, mixture, or preparation which contains any quantity of the following substances, including its salts, isomers, and salts of such isomers, whenever the existence of such salts, isomers, and salts of isomers is possible:

(f) Stimulants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers, (whether optical, position, or geometric), and salts of such isomers is possible within the specific chemical designation:

(g) Other substances. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation which contains any quantity of the following substances, including its salts:

(h) Any drug product exempted from control by the Federal Drug Enforcement Administration will also be exempted from the Alabama Controlled Substances List unless the State Committee of Public Health takes additional action.

Schedule V

(a) Schedule V shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this section.

(b) Narcotic drugs. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation containing any of the following narcotic drugs and their salts, as set forth below:

1. [Reserved]

(c) Narcotic drugs containing non-narcotic active medicinal ingredients. Any compound, mixture, or preparation containing any of the following narcotic drugs, or their salts calculated as the free anhydrous base or alkaloid, in limited quantities as set forth below, which shall include one or more non-narcotic active medicinal ingredients in sufficient proportion to confer upon the compound, mixture, or preparation valuable medicinal qualities other than those possessed by narcotic drugs alone:

(d) Stimulants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having stimulant effect on the central nervous system, including its salts, isomers and salts of isomers:

(e) Depressants. Unless specifically exempted or excluded or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts:

(f) Any drug product exempted from control by the Federal Drug Enforcement Administration will also be exempted from the Alabama Controlled Substances List unless the State Committee of Public Health takes additional action.

History

• Author: Dr. Jim McVay
• Authority: Code of Ala. 1975, §§20-2-20, et seq.
• Filed September 1, 1982. Publication of Controlled Substances List: Filed September 23, 1983. (Published in Vol. I, No. 12, AAM, September 30, 1983.) Amended: Filed June 22, 1984; July 24, 1984; September 27, 1984. Publication of Controlled Substances List: Filed September 27, 1984. (Published in Vol. III, No. 1, AAM, October 31, 1984.) Amended: Filed November 7, 1984; April 9, 1985; May 20, 1985; July 24, 1985; August 23, 1985. Publication of Controlled Substances List: Filed September 23, 1985. (Published in Vol. III, No. 12, AAM, September 30, 1985.) Amended: Filed December 30, 1985; February 20, 1986; April 22, 1986; May 23, 1986. Ed. Note: Continued temporary scheduling of 3-methylfentanyl at Schedule I, item (g)(1). Amended: Filed June 23, 1986; July 24, 1986. Ed. Note: Continued temporary scheduling of 3, 4-methylenedioxy -methamphetamine at Schedule I, item (g)(2). Amended: Filed September 23, 1986. Ed. Note: Continued temporary scheduling of 1-methyl-4phenyl-4-propionoxy piperidine (MPPP) and 1-(2-phenethyl)-phenyl-4-acetoxy- piperidine (PEPAP) at Schedule I, item (g)(3)(4). Publication of Controlled Substances List: Filed September 23, 1986. (Published in Vol. IV, No. 12, AAM, September 30, 1986.) Amended: Filed October 24, 1986; November 19, 1986; December 19, 1986. Ed. Note: Continued temporary scheduling of acetyl-alpha-methylfentanyl, alpha- methylthiofentanyl, beta-hydroxyfentanyl, beta-hydoxy-3- methylfentanyl, 3-methyl-thio-fentanyl and thiofentanyl at Schedule I, item (g)(3)(4)(6)(7)(8)(10). Amended: Filed February 20, 1987; April 23, 1987. Ed. Note: Continued temporary scheduling of parafluorofentanyl at Schedule I, item (g)(9). Amended: Filed April 23, 1987; June 23, 1987. Publication of Controlled Substances List: Filed September 23, 1987. (Published In Vol. V, No. 12, AAM, September 30, 1987.) Amended: Filed November 19, 1987; February 22, 1988; March 24, 1988; May 24, 1988; June 20, 1988; August 19, 1988; September 23, 1988. Publication of Controlled Substances List: Filed September 23, 1988. (Published in Vol. VI, No. 12, AAM, September 30, 1988.) Amended: Filed November 21, 1988. (Ed. Note: Continued scheduling of 3,4-methylenedioxy-N- ethylamphetamine, N-hydroxy-3, 4-methylenedioxyamphetamine and 4-methylaminorex in Schedule I, item (g), 3., 4., and 5.). Amended: Filed May 19, 1989; August 21, 1989. Publication of Controlled Substances List: Filed September 20, 1989. (Published in Vol. VII, No. 12, AAM, September 29, 1989.) Amended: Filed March 21, 1990. Publication of Controlled Substances List: Filed September 19, 1990. Published in Vol. VIII, No. 12, September 28, 1990.) Amended: Filed March 21, 1991; April 19, 1991. Publication of Controlled Substances List: Filed September 19, 1991. (Published in Vol. IX, No. 12, AAM, September 30, 1991.) Amended: Filed December 18, 1991; May 20, 1992; August 21, 1992. Amended: Filed September 21, 1992; Publication of Controlled Substances List: Filed September 21, 1992; (Published in Vol. XI, No. 1, AAM, October 30, 1992.) effective December 16, 1992. Amended: Filed May 20, 1993; effective June 24, 1993. Amended: Filed July 21, 1993; effective August 25, 1993. Publication of Controlled Substances List: Filed September 21, 1993. (Published in Vol. XI, No. 12, AAM, September 30, 1993). Amended: Filed October 20, 1993. Amended: Filed July 21, 1994; effective August 25, 1994. Publication of Controlled Substances List: Filed September 21, 1994. (Published in Vol. XII, No. 12, AAM, September 30, 1994). Publication of Controlled Substances List: Filed September 22, 1995. (Published in Vol. XIII, No. 12, AAM, September 29, 1995). Publication of Controlled Substances List: Filed September 20, 1996. (Published in Vol. XIV, No. 12, AAM, September 30, 1996). Effective December 20, 1996. Amended: Filed August 20, 1997; effective September 24, 1997. Publication of Controlled Substances List: Filed September 19, 1997. (Published in Vol. XV, No. 12, AAM, September 30, 1997). Amended: Filed November 20, 1997; effective December 25, 1997. Amended: Filed February 20, 1998; effective March 13, 1998. Amended: Filed August 20, 1998; effective September 24, 1998. Publication of Controlled Substances List: Filed September 18, 1998; (Published in Vol. XVI, No. 12, AAM, September 30, 1998.) effective October 1, 1998. Amended: Filed September 18, 1998; effective October 23, 1998. Amended: Filed February 19, 1999; effective February 26, 1999. Amended: Filed March 22, 1999; effective April 26, 1999. Amended: Filed August 20, 1999; effective August 1, 1999. Publication of Controlled Substances List: Filed September 17, 1999; (Published in Vol. XVII, No. 12, AAM, September 30, 1999.) Amended: Filed October 20, 1999; effective October 15, 1999. Amended: Filed March 17, 2000; effective April 12, 2000. Amended: Filed March 17, 2000; effective April 21, 2000. Amended: Filed November 20, 2000; effective December 25, 2000. Amended: Filed January 3, 2001; effective December 17, 2000. Publication of Controlled Substances List: Filed January 18, 2001; (Published in Vol. XIX, No. 4, AAM, February 1, 2001.) Amended: Filed September 20, 2001; effective September 15, 2001. Amended: Filed September 20, 2001; effective September 19, 2001. Publication of Controlled Substances List: Filed September 20, 2001; (Published in Vol. XIX, No. 12, AAM, September 28, 2001). Publication of Controlled Substances List: Filed September 18, 2002; (Published in Vol. XX, No. 12, AAM, September 30, 2002). Amended: Filed October 15, 2002; effective October 20, 2002. Amended: Filed October 15, 2002; effective November 6, 2002. Amended: Filed April 17, 2003; effective May 4, 2003. Publication of Controlled Substances List: Filed September 18, 2003; (Published in Vol. XXI, No. 12, AAM, September 30, 2003). Amended: Filed April 21, 2004; effective April 17, 2004. Publication of Controlled Substances List: Filed September 20, 2004; (Published in Vol. XXII, No. 12, AAM, September 30, 2004). Amended: Filed October 21, 2004; effective October 29, 2004. Amended: Filed April 20, 2005; effective May 4, 2005. Amended: Filed August 22, 2005; effective August 28, 2005. Publication of Controlled Substances List: Filed September 21, 2005; (Published in Vol. XXIII, No. 12, AAM, September 30, 2005). Publication of Controlled Substances List: Filed October 20, 2005; (Published in Vol. XXIV, No. 1, AAM, October 31, 2005). Publication of Controlled Substances List: Filed September 20, 2006; (Published in Vol. XXIV, No. 12, AAM, September 29, 2006). Amended: Filed October 19, 2006; effective October 28, 2006. Amended: Filed February 21, 2007; effective March 28, 2007. Amended: Filed June 20, 2007; effective July 4, 2007. Amended: Filed October 19, 2007; effective November 23, 2007. Publication of Controlled Substances List: Filed November 13, 2007; (Published in Vol. XXVI, No. 2, AAM, November 30, 2007). Publication of Controlled Substances List: Filed September 22, 2008; (Published in Vol. XXVI, No. 12, AAM, September 30, 2008). Amended: Filed June 26, 2009; effective July 22, 2009. Publication of Controlled Substances List: Filed September 17, 2009; (Published in Vol. XXVII, No. 12, AAM, September 30, 2009). Amended: Filed October 21, 2009; effective November 5, 2009. Publication of Controlled Substances List: Filed January 19, 2011; (Published in Vol. XXIX, No. 4, AAM, January 31, 2011). Amended: Filed March 17, 2011; effective March 31, 2011. Amended: Filed May 26, 2011; effective June 30, 2011. Amended: Filed December 21, 2011; effective January 1, 2012. Amended: Filed December 21, 2011; effective January 25, 2012. Publication of Controlled Substances List: Filed January 19, 2012; (Published in Vol. XXX, No. 4, AAM, January 31, 2012). Amended: Filed January 20, 2012; effective January 20, 2012. Amended: Filed July 23, 2012; effective August 27, 2012. Amended: Filed October 18, 2012; effective November 22, 2012. Amended: Filed January 2, 2013; effective January 20, 2013; (Published in Vol. XXXI, No. 4, AAM, January 31, 2013). Publication of Controlled Substances List: Filed January 17, 2013; (Published in Vol. XXXI, No. 4, AAM, January 31, 2013). Amended: Filed February 20, 2013; effective February 3, 2013; (Published in Vol. XXXI, No. 5, AAM, February 28, 2013). Amended: Filed April 12, 2013; effective May 17, 2013. Amended: Filed June 20, 2013; effective June 16, 2013; (Published in Vol. XXXI, No. 9, AAM, June 28, 2013). Amended: Filed January 2, 2014; effective February 2, 2014; (Published in Vol. XXXII, No. 4, AAM, January 31, 2014). Publication of Controlled Substances List: Filed February 20, 2014; (Published in Vol. XXXII, No. 5, AAM, February 28, 2014). Amended: Filed February 28, 2014; effective March 10, 2014; (Published in Vol. XXXII, No. 6, AAM, March 31, 2014). Amended: Filed March 20, 2014; effective April 7, 2014; (Published in Vol. XXXII, No. 6, AAM, March 31, 2014). Amended: Filed March 20, 2014; effective April 30, 2014; (Published in Vol. XXXII, No. 6, AAM, March 31, 2014). Amended: Filed June 20, 2014; effective July 25, 2014. Amended: Filed July 24, 2014; effective September 18, 2014; (Published in Vol. XXXII, No. 11, AAM, August 29, 2014). Amended: Filed September 19, 2014; effective October 29, 2014; (Published in Vol. XXXII, No. 12, AAM, September 30, 2014). Amended: Filed September 19, 2014; effective November 6, 2014; (Published in Vol. XXXII, No. 12, AAM, September 30, 2014). Publication of Controlled Substances List: Filed January 23, 2015; (Published in Vol. XXXIII, No. 4, AAM, January 30, 2015). Amended: Filed February 19, 2014; effective March 1, 2015; (Published in Vol. XXXIII, No. 5, AAM, February 27, 2015). Amended: Filed February 19, 2015; effective February 23, 2015; (Published in Vol. XXXIII, No. 5, AAM, February 27, 2015). Amended: Filed September 17, 2015; effective October 11, 2015; (Published in Vol. XXXIII, No. 12, AAM, September 30, 2015). Amended: Filed November 19, 2015; effective December 13, 2015; (Published in Vol. XXXIV, No. 2, AAM, November 30, 2015). Amended: Filed December 18, 2015; effective February 1, 2016. Publication of Controlled Substances List: Filed January 20, 2016; (Published in Vol. XXXIV, No. 4, AAM, January 29, 2016). Amended: Filed May 19, 2016; effective June 15, 2016; (Published in Vol. XXXIV, No. 8, AAM, May 31, 2016). Amended: Filed July 20, 2016; effective June 10, 2016; (Published in Vol. XXXIV, No. 10, AAM, July 31, 2016). Amended: Filed September 21, 2016; effective October 6, 2016; (Published in Vol. XXXIV, No. 12, AAM, September 30, 2016). Amended: Filed October 20, 2016; effective November 26, 2016; (Published in Vol. XXXV, No. 1, AAM, October 31, 2016). Amended: Filed November 17, 2016; effective December 14, 2016; (Published in Vol. XXXV, No. 2, AAM, November 30, 2016). Amended: Filed December 15, 2016; effective December 28, 2016; (Published in Vol. XXXV, No. 3, AAM, December 30, 2016). Publication of Controlled Substances List: Filed January 18, 2017; (Published in Vol. XXXV, No. 4, AAM, January 31, 2017). Amended: Filed March 16, 2017; effective April 8, 2017; (Published in Vol. XXXV, No. 6, AAM, March 31, 2017). Amended: Filed July 21, 2017; effective August 13, 2017; (Published in Vol. XXXV, No. 10, AAM, July 31, 2017). Amended: Filed October 19, 2017; effective October 28, 2017; (Published in Vol. XXXVI, No. 1, AAM, October 31, 2017). Amended: Filed October 19, 2017; effective November 15, 2017; (Published in Vol. XXXVI, No. 1, AAM, October 31, 2017). Amended: Filed January 19, 2018; effective December 22, 2017; (Published in Vol. XXXVI, No. 4, AAM, January 31, 2018). Publication of Controlled Substances List: Filed February 21, 2018; (Published in Vol. XXXVI, No. 5, AAM, February 28, 2018). Amended: Filed May 18, 2018; effective May 20, 2018; (Published in Vol. XXXVI, No. 8, AAM, May 31, 2018). Amended: Filed July 19, 2018; effective September 2, 2018. Amended: Filed October 18, 2018; effective October 28, 2018; (Published in Vol. XXXVII, No. 1, AAM, October 31, 2018). Amended: Filed December 13, 2018; effective December 29, 2018; (Published in Vol. XXXVII, No. 3, AAM, December 28, 2018). Publication of Controlled Substances List: Filed January 10, 2019; (Published in Vol. XXXVII, No. 4, AAM, January 31, 2019). Amended: Filed February 20, 2019; effective February 28, 2019. (Published in Vol. XXXVII, No. 5, AAM, February 28, 2019). Amended: Filed February 20, 2019; effective March 9, 2019. (Published in Vol. XXXVII, No. 5, AAM, February 28, 2019). Amended: Filed May 17, 2019; effective June 7, 2019. (Published in Vol. XXXVII, No. 8, AAM, May 31, 2019). Amended: Filed May 17, 2019; effective July 1, 2019. (Published in Vol. XXXVII, No. 8, AAM, May 31, 2019). Amended: Filed July 17, 2019; effective July 17, 2019 and July 18, 2019. (Published in Vol. XXXVII, No. 10, AAM, July 31, 2019). Amended: Filed August 21, 2019; effective September 15, 2019. (Published in Vol. XXXVII, No. 11, AAM, August 30, 2019). Amended: Filed November 20, 2019; effective November 24, 2019. (Published in Vol. XXXVIII, No. 2, AAM, November 29, 2019). Publication of Controlled Substances List: Filed January 21, 2020; (Published in Vol. XXXVIII, No. 4, AAM, January 31, 2020). Amended: Filed February 19, 2020; effective February 23, 2020. (Published in Vol. XXXVIII, No. 5, AAM, February 28, 2020). Amended: Filed April 17, 2020; effective April 29, 2020. (Published in Vol. XXXVIII, No. 7, AAM, April 30, 2020). Amended: Filed May 20, 2020; effective June 17, 2020. (Published in Vol. XXXVIII, No. 8, AAM, May 29, 2020). Amended: Filed September 16, 2020; effective September 19, 2020. (Published in Vol. XXXVIII, No. 12, AAM, September 30, 2020). Amended: Filed October 20, 2020; effective November 1, 2020. (Published in Vol. XXXIX, No. 1, AAM, October 30, 2020). Amended: Filed December 17, 2020; effective December 25, 2020. (Published in Vol. XXXIX, No. 3, AAM, December 31, 2020). Publication of Controlled Substances List: Filed January 20, 2021; (Published in Vol. XXXIX, No. 4, AAM, January 29, 2021). Amended: Published January 29, 2021; effective March 15, 2021. Amended: Filed March 22, 2021; effective April 2, 2021. (Published in Vol. XXXIX, No. 6, AAM, March 31, 2021). Amended: Filed May 19, 2021; effective May 19, 2021. (Published in Vol. XXXIX, No. 8, AAM, May 28, 2021). Amended: Filed May 19, 2021; effective May 27, 2021. (Published in Vol. XXXIX, No. 8, AAM, May 28, 2021). Amended: Filed May 19, 2021; effective June 3, 2021. (Published in Vol. XXXIX, No. 8, AAM, May 28, 2021). Amended: Filed June 17, 2021; effective June 23, 2021. (Published in Vol. XXXIX, No. 9, AAM, June 30, 2021). Amended: Filed June 17, 2021; effective July 10, 2021. (Published in Vol. XXXIX, No. 9, AAM, June 30, 2021). Amended: Filed June 17, 2021; effective August 1, 2021. (Published in Vol. XXXIX, No. 9, AAM, June 30, 2021). Amended: Filed June 17, 2021; effective August 11, 2021. (Published in Vol. XXXIX, No. 9, AAM, June 30, 2021). Amended: Filed July 17, 2021; effective July 14, 2021. (Published in Vol. XXXIX, No. 10, AAM, July 30, 2021). Amended: Filed July 17, 2021; effective July 22, 2021. (Published in Vol. XXXIX, No. 10, AAM, July 30, 2021). Amended: Published July 30, 2021; effective September 13, 2021. Amended: Published September 30, 2021; effective November 14, 2021. Publication of Controlled Substances List: Filed January 20, 2022; (Published in Vol. XL, No. 4, AAM, January 31, 2022). Amended: Published May 31, 2022; effective July 15, 2022. Amended: Published June 30, 2022; effective July 1, 2022, and July 6, 2022. (Published in Vol. XL, No. 9, AAM, June 30, 2022.) Amended: Published July 29, 2022; effective August 24, 2022. (Published in Vol. XL, No. 10, AAM, July 29, 2022.) Amended: Published October 31, 2022; effective November 30, 2022. (Published in Vol. XLI, No. 1, AAM, October 31, 2022.) Amended: Published November 30, 2022; effective January 5, 2022. (Published in Vol. XLI, No. 2, AAM, November 30, 2022.) Amended: Published November 30, 2022; effective May 7, 2022. (Published in Vol. XLI, No. 2, AAM, November 30, 2022.) Amended: Published December 30, 2022; effective January 8, 2023; January 18, 2023; January 20, 2023; and January 21, 2023. (Published in Vol. XLI, No. 3, AAM, December 30, 2022.) Amended: Published December 30, 2022; effective February 13, 2023. Publication of Controlled Substances List: Published January 31, 2023; (Published in Vol. XLI, No. 4, AAM, January 31, 2023). Amended: Published January 31, 2023; effective January 19, 2023. Amended: Published May 31, 2023; approved May 18, 2023. (Published in Vol. XLI, No. 8, AAM, May 31, 2023.) Amended: Published July 31, 2023; effective September 14, 2023. Amended (Schedule I(b)93 and Schedule III(f)1-89): Published September 29, 2023; approved September 21, 2023. (Published in Vol. XLI, No. 12, AAM, September 29, 2023.) Amended: Published February 29, 2024; effective January 6, 2024. Amended: Published February 29, 2024; effective January 12, 2024. Amended: Published April 30, 2024; effective May 15, 2024. Amended: Published May 31, 2024; approved May 16, 2024 (Published in Vol. XLII, No. 8, May 31, 2024). Amended: Published May 31, 2024; effective July 15, 2024. Amended: Published September 30, 2024; effective October 13, 2024. Amended: Published November 27, 2024; effective November 21, 2024. Amended: Published December 31, 2024; effective November 24, 2024. Amended: Published April 30, 2025; effective June 14, 2025. Amended: Published September 30, 2025; effective October 7, 2025. Amended: Published November 26, 2025; effective October 18, 2025. Amended: Published December 31, 2025; effective February 14, 2026. Amended: Published February 27, 2026; effective February 19, 2026. Amended: Published March 31, 2026; effective March 19, 2026. Amended: Published April 30, 2026; effective April 9, 2026. Amended: Published June 30, 2026; effective May 22, 2026. Amended: Published June 30, 2026; effective June 18, 2026.